Integrated DNA Technologies (IDT) introduces its rhAmpSeq targeted sequencing system, which aims to provide accurate, cost-effective, and easy-to-use amplicon sequencing on Illumina next-generation sequencing (NGS) platforms. The proprietary rhAmpSeq chemistry enables multiplexing with high on-target rates and uniform coverage, delivering accurate results. The system’s applications include human disease sample tracking and analysis, CRISPR genome editing analysis, and more. The rhAmpSeq system enables high multiplexing levels, minimizing the number of reagents needed and helping to lower costs due to its ability to minimize primer-dimer formation and misprimed PCR products. A streamlined workflow generates NGS-ready amplicon libraries in just two PCR steps. IDT has optimized the rhAmpSeq system for consistent performance across panel sizes from tens to thousands of amplicons in a single multiplex reaction, and the system can be used with either a regular or high-throughput protocol to match individual needs. In addition, the rhAmpSeq system is highly versatile, as the technology enables the design of large custom panels with flexible amplicon sizes that can be tailored for various applications and sample types.

Integrated DNA Technologies